Notwithstanding occasional bear rallies, global capital markets have seen a severe correction since September 2008. This has taken the valuations of PE portfolios marked to public markets under FAS 157 sharply downward as well. But is marking PE portfolios to public markets an accurate reflection of their true and fair value in exuberant or depressed conditions?
Western European and North American economies have seen a significant slowdown with consumer confidence drying up simultaneously with consumer credit. This is pushing many companies into distressed or recovery positions. The big question being asked by LPs in these jurisdictions is, "Why should I invest in Asian growth when I have plenty of recovery deals at home?"
This forum features leading Asian GPs explaining why staying at home means missing out on some compelling opportunities, as well as highlighting how exits are likely to be achievable in Asia over the next 3 to 4 years. An event not to be missed whether you're a US limited partner considering investment in, or already committed to Asian PE, or an Asian GP needing a read on the zeitgeist among US LPs.
Confirmed speakers (partial list)
Co-sponsors
Supporting organisations
Media partners
Knowledge partner